Healthcare Business Roundup: CollabRx Partners With Life, Johnson & Johnson Accused By FDA

The data analytics firm CollabRx (NASDAQ:CLRX) announces a multiyear partnership with Life Technologies Corporation (NASDAQ:LIFE) through which its tech will be joined with Life’s cancer panels.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Shares of Escalon Medical (NASDAQ:ESMC) closed up more than 150 percent on the day, following the divestiture of its clinical diagnostics unit to Erba Diagnostics (AMEX:ERB) for $6.5 million. The firm points out that the transaction should have a material effect on future earnings.

Johnson & Johnson (NYSE:JNJ) is said to have violated the law when it marketed its antipsychotic drug Risperdal for use in children and teens, says former FDA commissioner David Kessler, according to The Philadelphia Inquirer’s PhillyPharma blog, which cited court documents.

Don’t Miss: Here’s a New Treatment for Muscular Dystrophy.